Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 12, 2014
Reliability and validity of a novel haemophilia-specific self-efficacy scaleJ Lock, H Raat, M Peters, et al.Digestive Diseases and Sciences|February 1, 1994
A prospective study of effects of Belsey MK IV antireflux surgery on endoscopic esophagitis, lower esophageal sphincter pressure, and 24-hr pH measurements. Relation to symptom improvementJ M Horbach, M H Cnossen, J B Jansen, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 4, 2015
Side effects of desmopressin in patients with bleeding disordersS C M Stoof, M H Cnossen, M P M de Maat, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|March 31, 2012
The group medical appointment (GMA) in haemophilia and von Willebrand's disease: a new development in outpatient paediatric careJ Lock, A De Bruin, M Scholten, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|October 26, 2016
Optimization of home treatment in haemophilia: effects of transmural support by a haemophilia nurse on adherence and quality of lifeJ Lock, H Raat, M Peters, et al.Journal of Medical Genetics|August 27, 1998
Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's HospitalM H Cnossen, K G Moons, M P Garssen, et al.Blood Reviews|February 11, 2018
Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play?H C A M Hazendonk, I van Moort, R A A Mathôt, et al.European Journal of Clinical Pharmacology|October 15, 2021
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patientsT Preijers, M W F van Spengler, K Meijer, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 28, 2014
Adherence to treatment in a Western European paediatric population with haemophilia: reliability and validity of the VERITAS-Pro scaleJ Lock, H Raat, N Duncan, et al.Journal of Medical Screening|December 21, 2011
Relationship between neonatal screening results by HPLC and the number of α-thalassaemia gene mutations; consequences for the cut-off valueM J Bouva, C Sollaino, L Perseu, et al.Pageof 4